{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:50:40Z","timestamp":1740138640187,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijid.2020.08.044","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T06:44:36Z","timestamp":1597905876000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Persistent high levels of immune activation and their correlation with the HIV-1 proviral DNA and 2-LTR circles loads, in a cohort of Mexican individuals following long-term and fully suppressive treatment"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-883X","authenticated-orcid":false,"given":"Aurelio","family":"Orta-Resendiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Viveros-Rogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-7753","authenticated-orcid":false,"given":"Luis L.","family":"Fuentes-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises","family":"Vergara-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damaris P.","family":"Romero-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Mu\u00f1oz-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha L.","family":"Zancatl-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa Y.","family":"Vidal-Laurencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto A.","family":"Rodriguez-Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Soto-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.08.044_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","article-title":"Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection","volume":"2","author":"Ananworanich","year":"2016","journal-title":"J Virus Erad."},{"issue":"February (2)","key":"10.1016\/j.ijid.2020.08.044_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/088922204773004950","article-title":"CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy","volume":"20","author":"Benito","year":"2004","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"April (4)","key":"10.1016\/j.ijid.2020.08.044_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.qai.0000153105.42455.c2","article-title":"Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy","volume":"38","author":"Benito","year":"2005","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"December (12)","key":"10.1016\/j.ijid.2020.08.044_bib0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med."},{"issue":"April (3)","key":"10.1016\/j.ijid.2020.08.044_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/157016211795945296","article-title":"HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS","volume":"9","author":"d\u2019Ettorre","year":"2011","journal-title":"Curr HIV Res."},{"issue":"August (4)","key":"10.1016\/j.ijid.2020.08.044_bib0030","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood."},{"issue":"October (4)","key":"10.1016\/j.ijid.2020.08.044_bib0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity."},{"issue":"September (15)","key":"10.1016\/j.ijid.2020.08.044_bib0040","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/QAD.0b013e32833d214c","article-title":"Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen","volume":"24","author":"Delaugerre","year":"2010","journal-title":"AIDS"},{"issue":"February (2)","key":"10.1016\/j.ijid.2020.08.044_bib0045","article-title":"Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies","volume":"9","author":"Eriksson","year":"2013","journal-title":"PLoS Pathog."},{"issue":"April (4)","key":"10.1016\/j.ijid.2020.08.044_bib0050","article-title":"Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation","volume":"13","author":"Gandhi","year":"2017","journal-title":"PLoS Pathog."},{"issue":"April (4)","key":"10.1016\/j.ijid.2020.08.044_bib0055","article-title":"Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV","volume":"12","author":"Hill","year":"2016","journal-title":"PLoS Pathog."},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.08.044_bib0060","article-title":"A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers","volume":"6","author":"Hunt","year":"2011","journal-title":"PLoS One."},{"issue":"April (2)","key":"10.1016\/j.ijid.2020.08.044_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10408363.2013.865702","article-title":"Role of inflammation in HIV-1 disease progression and prognosis","volume":"51","author":"Ipp","year":"2014","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"October (8)","key":"10.1016\/j.ijid.2020.08.044_bib0070","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/infdis\/jit311","article-title":"Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size","volume":"208","author":"Jain","year":"2013","journal-title":"J Infect Dis."},{"issue":"April (8)","key":"10.1016\/j.ijid.2020.08.044_bib0075","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/597476","article-title":"Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection","volume":"199","author":"Jiang","year":"2009","journal-title":"J Infect Dis."},{"issue":"March (2)","key":"10.1016\/j.ijid.2020.08.044_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/COH.0000000000000228","article-title":"Immune activation during acute HIV infection and the impact of early antiretroviral therapy","volume":"11","author":"Krebs","year":"2016","journal-title":"Curr Opin HIV AIDS."},{"key":"10.1016\/j.ijid.2020.08.044_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Residual immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv Immunol."},{"issue":"July (2)","key":"10.1016\/j.ijid.2020.08.044_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study","volume":"55","author":"L\u00e9vy","year":"2012","journal-title":"Clin Infect Dis."},{"issue":"January (3)","key":"10.1016\/j.ijid.2020.08.044_bib0095","first-page":"343","article-title":"The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption","volume":"30","author":"Li","year":"2016","journal-title":"AIDS."},{"issue":"October (2)","key":"10.1016\/j.ijid.2020.08.044_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00042560-199710010-00003","volume":"16","author":"Liu","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"issue":"March (3)","key":"10.1016\/j.ijid.2020.08.044_bib0105","article-title":"Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection","volume":"10","author":"M\u00e1rquez","year":"2015","journal-title":"PLoS One"},{"issue":"July (5)","key":"10.1016\/j.ijid.2020.08.044_bib0110","article-title":"Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence","volume":"24","author":"Miller","year":"2018","journal-title":"Cell Rep."},{"issue":"January (1)","key":"10.1016\/j.ijid.2020.08.044_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/83381","article-title":"Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis","volume":"7","author":"Napolitano","year":"2001","journal-title":"Nat Med."},{"issue":"March (10)","key":"10.1016\/j.ijid.2020.08.044_bib0120","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy","volume":"105","author":"Palmer","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"issue":"February (3)","key":"10.1016\/j.ijid.2020.08.044_bib0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1086\/380793","article-title":"CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy","volume":"38","author":"Resino","year":"2004","journal-title":"Clin Infect Dis."},{"issue":"May (5)","key":"10.1016\/j.ijid.2020.08.044_bib0130","article-title":"HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality","volume":"10","author":"Serrano-Villar","year":"2014","journal-title":"PLoS Pathog."},{"issue":"June (6)","key":"10.1016\/j.ijid.2020.08.044_bib0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1203\/00006450-200206000-00013","article-title":"CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients","volume":"51","author":"Sherman","year":"2002","journal-title":"Pediatr Res"},{"issue":"May (1)","key":"10.1016\/j.ijid.2020.08.044_bib0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QAI.0b013e3182895af4","article-title":"CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy","volume":"63","author":"Taiwo","year":"2013","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"June (6)","key":"10.1016\/j.ijid.2020.08.044_bib0145","first-page":"1141","article-title":"CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy","volume":"117","author":"Tarancon-Diez","year":"2017","journal-title":"Thromb Haemost."},{"issue":"March (2)","key":"10.1016\/j.ijid.2020.08.044_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COH.0000000000000242","article-title":"Role of immune activation in progression to AIDS","author":"Utay","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"May (21)","key":"10.1016\/j.ijid.2020.08.044_bib0155","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2012-11-465625","article-title":"Interleukin-7 promotes HIV persistence during antiretroviral therapy","volume":"121","author":"Vandergeeten","year":"2013","journal-title":"Blood"},{"issue":"February (4)","key":"10.1016\/j.ijid.2020.08.044_bib0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"issue":"September (8)","key":"10.1016\/j.ijid.2020.08.044_bib0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hiv.12134","article-title":"Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals","volume":"15","author":"Zoufaly","year":"2014","journal-title":"HIV Med."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220306731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:55:14Z","timestamp":1738450514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220306731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":33,"alternative-id":["S1201971220306731"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.044","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent high levels of immune activation and their correlation with the HIV-1 proviral DNA and 2-LTR circles loads, in a cohort of Mexican individuals following long-term and fully suppressive treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}